Skip to main content
Smart Investors Daily
908 Devices Inc. logo

NASDAQ · MASS

908 Devices Inc.

Healthcare · Medical - Devices

$10.21

Up+$0.46 (+4.51%)

Updated Nov 3, 2026, 10:18 PM

SID Score

4.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
231.99M
P/E ratio
-56.02
Dividend yield
0.00%
52-week range
$5.03 – $13.35
Volume
444.75K
Avg. volume
390.2K

Price performance · MASS

MASS price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 2, 2026

MASS closed at $10.21 after 21 trading sessions, down 20.23% for the selected period.

Last close
$10.21
Period change
-20.23%
Period low
$10.21
Period high
$12.87
Daily close
View OHLC price history
MASS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 2, 2026$11.35$11.52$10.16$10.21444.75K
Oct 30, 2026$12.44$12.60$10.92$11.25551.09K
Oct 29, 2026$12.51$12.94$12.45$12.85223.03K
Oct 28, 2026$12.46$12.93$12.30$12.87298.99K
Oct 27, 2026$11.91$12.42$11.64$12.36426.85K
Oct 26, 2026$11.58$11.895$11.43$11.65284.05K
Oct 23, 2026$11.31$11.49$11.05$11.49232.01K
Oct 22, 2026$11.58$11.78$11.15$11.35256.52K
Oct 21, 2026$11.88$11.975$11.4425$11.80570.31K
Oct 20, 2026$11.38$11.86$11.18$11.51369.73K
Oct 19, 2026$11.43$11.705$11.34$11.43309.21K
Oct 16, 2026$11.88$12.1652$11.245$11.26469.22K
Oct 15, 2026$11.55$12.11$11.52$11.89274.63K
Oct 14, 2026$11.81$12.1572$11.775$11.83411.61K
Oct 13, 2026$11.82$12.13$11.645$12.09230.4K
Oct 12, 2026$12.22$12.22$11.5338$11.82230.92K
Oct 9, 2026$11.59$12.19$11.59$12.05323.11K
Oct 8, 2026$11.66$11.69$11.14$11.55448.05K
Oct 7, 2026$12.10$12.13$11.745$11.78517.21K
Oct 6, 2026$12.85$13.348$12.25$12.33377.28K
Oct 5, 2026$12.69$12.86$12.20$12.80419.45K

Latest MASS news

The latest Smart Investors Daily articles mentioning MASS.

MASS research

Overview

Company profile and research snapshot.

Company profile

908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
MASS recent ratings
DateFirmRatingTarget
Sep 10, 2026Canaccord GenuityBuy—
Aug 12, 2026Roth CapitalBuy—
Aug 12, 2026StifelBuy—
Jul 29, 2026Roth CapitalBuy—
Aug 5, 2025Leerink PartnersOutperform—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.